4 Stocks Feeling The Heat From Downgrades, Weak Earnings

Page 2 of 2

Infoblox Inc. (NYSE:BLOX) has rolled downhill by 10.48% today following a downgrade from Deutsche Bank to ‘Sell’ from ‘Hold’. The downgrade comes with a $17 cut in the investment bank’s price target on the stock as well, to $13 per share. Infoblox, a critical network services provider, is set to hold an earnings conference call on November 30 to discuss its first quarter of fiscal year 2016 results.

By the end of September, 24 funds in our database held 22.00% of Infoblox Inc. (NYSE:BLOX)’s outstanding stock. Eric Bannasch’s Cadian Capital was the owner of 5.33 million shares worth $85.15 million on September 30.

Follow Infoblox Inc (NYSE:BLOX)

Lastly, Exact Sciences Corp. (NASDAQ:EXAS) has slumped by 7.12% after receiving a price target reduction of its own, as Lake Street Capital lowered its price target on the company to $7 from $12. While the firm has a ‘Hold’ rating on the stock, its price target represents fairly significant downside of over 22%. Most recently, the molecular diagnostics company said it continues to work with the city of Madison, Wisconsin, to set up a headquarters there as well as build a biotech campus.

“This is an opportunity to work with the city, build on our current footprint in Madison and partner with the University to continue grooming its aspiring talent,” Exact Sciences Chairman and CEO Kevin Conroy said.

17 out of the 730 funds in our database held 9.20% of Exact Sciences Corp. (NASDAQ:EXAS)’s outstanding stock at the end of the third quarter. Samuel Isaly‘s Orbimed Advisors holds 1.78 million shares of the company, valued at $32 million.

Follow Exact Sciences Corp (NASDAQ:EXAS)

Disclosure: None

Page 2 of 2